… inhibited cell division through the underlying mechanism of downregulating COX, topoisomerase
II enzyme TPA, and EROD protein activity [96]. Followed by angiogenesis, GNT (15–30 …

… -breast cancer drugs and genistein by inhibition of breast arterial calcifications. These
findings could lead to possibility of finding new combinations of chemotherapeutic drugs, along …

… role is played by the Notch-1 pathway where the NF-κB inhibition activity by genistein is
induced in triple-negative breast cancer (TNBC), which is the worst type of breast cancer. …

… In breast cancer, genistein can inhibit cell differentiation and proliferation, moreover, the
anti-cancer potential of genistein … -mediated AMPK activation proved as a potential therapeutic …

… have also surfaced as potential therapeutic targets of interest … MB-231 human breast cancer
cells, and decreased expression … By blocking it, whether by specific inhibitors or by genistein, …

… highlight the known inhibitory effects of genistein regarding the … of genistein in breast cancer
cells are the NF-κB and AKT pathways [102,103]. Furthermore, genistein suppresses cancer …

… mechanisms by which GE elicits its anti-carcinogenic properties involve inhibition of cellular
… differentiation, and cell cycle arrest at the G2-M phase [11,12,13]. Specifically, it is known to …

… inhibition by genistein. According to the result of this study, genistein was understood as a
better inhibitor of NF-κB1 that plays a key role in the inhibition of breast cancer. The findings …

… anti-cancer mechanisms of Genistein in multiple BC cells were analyzed, mechanism of …
is an antibiotic that exhibits no inhibitory effects on Adriamycin resistance breast cancer cell. …

… Genistein is an inhibitor of the growth of breast cancer cell lines, MDA-468 (estrogen receptor
negative), and MCF-7 and MCF-7-D-40 (estrogen receptor positive) (IC 50 values ranging …